US 12030925
Methods of treating hemophilia A
granted A61KA61K38/00A61K38/36
Quick answer
US patent 12030925 (Methods of treating hemophilia A) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61K38/36, A61K38/37, A61P